恒瑞医药：截至2025年8月20日前十大流通股东持股占比59.79%

Group 1 - Heng Rui Medicine announced a share buyback plan to implement an employee stock ownership plan using its own funds through centralized bidding [1] - The top ten unrestricted shareholders hold approximately 3.982 billion shares, accounting for 59.79% of the total shares [1] - The largest shareholder is Jiangsu Heng Rui Medicine Group Co., Ltd., holding about 1.538 billion shares, which is 23.18% of the total [1] Group 2 - In 2024, Heng Rui Medicine's revenue composition shows that the pharmaceutical manufacturing industry accounts for 89.37%, while other businesses account for 10.63% [2] - As of the latest report, Heng Rui Medicine's market capitalization is 433.4 billion yuan [3]